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of increased participation and use of the STS GTDB.
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Dr Antoon Lerut (Leuven, Belgium). Congratulations on this
excellent presentation and thank you for sending me the manu-
script well in advance.
I consider this type of study as being a typical sort of playground
for investigators with a master’s degree in public health or holding
some other master’s degree in science, all of which I am not. That
is the only disclosure I have to make. Also, I noticed that this is the
fifth presentation in this meeting of a report that to some extent re-
lates to the topic of volume and outcomes. That is about 10% of all
presentations, which I think comes close to the definition of an ep-
idemic. But, anyway, I will give it a try.
My first observation is that the number of surgeries for esopha-
geal cancer registered, and I presume these are the factual surger-
ies, are increasing steadily in all databases. The second observation
is that the mortality is decreasing slowly, and except for the year
2008 that was in the report, this figure is most prominent in the
NIS database, decreasing from 8% in 2002 to 3% in 2007, closing
the gap between the NIS and the 2 other databases. I would say that
is good news for the patients and also for the surgeons.
I have 3 questions. First, you indicated that comorbidities, such
as chronic obstructive pulmonary disease (COPD), which are seen
as risk factors for esophageal cancer resection were greater in the
GTDB than in the NSQIP database. I wonder whether these data-
bases use the same definitions for the values related to each of the
comorbidities. For example, COPD Global Initiative for Chronic
Obstructive Lung Disease class 1 and COPD Global Initiative
for Chronic Obstructive Lung Disease class 2 both match the def-
inition of COPD but clearly represent differing severity of the dis-
ease. That could, of course, be a source a bias. In other words, are
you comparing the same severity of disease for each of these
comorbidities?
Dr Kozower. Thank you very much for your comments. As you
correctly point out, the definitions for various comorbidities, such
as COPD, are different for the different databases. Wewere careful
to point this out and tried not to overinterpret the data.
Dr Lerut. The second question relates to the fact that for about
2 decades the relationship between procedure volume and better
outcome has been accepted; however, more recently, it has been
postulated that volume per se does not translate into better out-
comes. Rather, it is the factors associated with it, such as surgeon
expertise, perioperative management, and so forth. Therefore,
procedure volume should not be used as a measure of quality, as
Dr LaPar from your group so strongly advocated last Friday atdiovascular Surgery c Volume 144, Number 5 1157
General Thoracic Surgery LaPar et al
G
T
Sthe American Surgical Association meeting. I understand that both
the GTDB and the NSQIP database include a number of low-vol-
ume centers. Because both databases show a very low mortality
rate, this seems to confirm that volume on its own is an inadequate
parameter of quality measurement. Nevertheless, we keep hearing
that esophagectomy needs to be centralized to high-volume cen-
ters, and I think all of us would like to be operated for esophageal
carcinoma in a high-volume center. So, if it is not volume, what is
it that we should bring forward to endorse such a plea in favor of
centralization? What do we have to advise to our healthcare poli-
cymakers, because they are using that type of data.
Dr Kozower. Your question is obviously a very important one,
but you are asking me for kind of the ‘‘Holy Grail’’ of quality.
However, we do not fully understand what distinguishes high-
and low-performing hospitals. I think expertise is obviously ex-
tremely important and quality is a multidimensional concept. So
what we have argued so strongly against is trying to oversimplify
it and simply use volume as a proxy for quality, particularly when
that alone will be used to direct patient referrals. However, factors
are present at these high-volume hospitals that are associated with
good outcomes. Thus, our group and others are currently working
to identify these factors.
Dr Lerut.Well, I would think that is a lot of work ahead, but I
think it is important that we try to find these elements, because that
is not what the policymakers and insurance companies are using.
Also, as I said, I presume that everybody in this room would like
to be operated in a high-volume center rather than in a low-volume
center. So volume does matter, right?
Dr Kozower. I do not think the data support using volume as
a proxy for quality. Even using the STS GTDB, when you consider
Cam Wright’s paper on esophagectomy, volume was not a signifi-
cant predictor of mortality or major morbidity. Importantly, more
than one half of the centers are what are classically thought of as
low volume, and the results are more generalizable.
Dr Lerut. You mentioned that the GTDB and the NSQIP data-
base represent only a small proportion, 36% and 11%, respectively,
of the estimated number of resections performed nationwide.
Given the comparable results, is it not time to link those 2 databases
to generate a larger effort and therefore a stronger sample? This
would allow us to better convince the outside world that patients
should be treated by board-certified surgeons, whether thoracic
surgeons or specialist upper gastrointestinal surgeons. I come
from a part of the world where I am more frequently confronted
with the fact that upper gastrointestinal surgeons are involved in
performing this type of surgery with excellent results. I would
like to hear your comments on how you see this in this country.
Dr Kozower. While I am not in charge of setting US policy, I
strongly believe that it is the surgical outcomes that should be
used to judge the surgeon and not any arbitrary predictor. There-
fore, it is going to be very important for us to determine how to
measure and differentiate surgical and hospital performance. The
STS database has demonstrated significantly better outcomes,
and so it is not hard to convince this crowd that esophageal cancer
should be performed by those of us sitting in the room. How do you
do that for the whole country, and are we actually available to the
whole country? These are very complicated issues. Canada is start-
ing to figure this out, and they have been presenting their series
with regionalization of care. Some of the results seem quite1158 The Journal of Thoracic and Cardiovascular Surgood and some of them actually have not shown as large a decrease
in mortality as one might think.
Dr Lerut. Would you make an effort to combine the 2 data-
bases and try to come up with a greater percentage and therefore
be able to make stronger statements on just the idea to centralize
patients?
Dr Kozower. I do not think I would want to combine the 2 da-
tabases, because they have very different purposes. The NSQIP
was established for general and vascular surgery and uses a sam-
pling method to capture thoracic procedures, such as esophagec-
tomy, performed at a given hospital. Certain hospitals use the
NSQIP to capture every case they perform, but, overall, that is
not the sampling method.
Dr Lerut. I thank the Association for the privilege to discuss
this paper.
Dr David J. Sugarbaker (Boston, Mass). I have 1 question and
comment regarding the STS database and NSQIP or the adminis-
trative, and that is that I am not sure people are aware that the fun-
damental difference between the NSQIP and STS database, and
one of the disadvantages of the STS database, could be that it
uses elective data submission. So, the data submission for STS is
retrospective, occurring after the procedure, usually after dis-
charge, and selection bias in any type of protocol in which that
is the case is certainly recognized as a problem. The NSQIP is
a real-time snapshot of what is happening, and the administrative
database is, again, a nonelective submission of data, usually elec-
tronically. The STS database is helpful, but it is not an intent-to-
treat, prospective registration of patients that in most assessments
would give one a clearly accurate assessment of what is occurring.
Do you want to comment on that?
DrKozower.You are absolutely correct. The only point I would
add is that the latest version of the database differentiates between
major and minor procedures and requires that all major procedures
be reported. External audits are being used to verify the accuracy
of the data submitted and to verify that major cases, perhaps with
poor outcomes, are not being omitted. The results these audits will
obviously be extremely important.
Dr Sugarbaker. I would just say, if you know, particularly in
the cardiac world, what pressure institutions are under for out-
comes, you could be concerned that in particular centers tremen-
dous pressure exists to produce excellent outcomes, not that
anybody is going to alter that, but there is tremendous pressure.
Dr Alexander Krupnick (St. Louis, Mo). Going along with Dr
Sugarbaker’s question, is 1 of these databases audited by
insurance companies? In other words, does this reporting affect re-
imbursement? Could some of the comorbidities be overexagger-
ated in 1 database and reported more accurately in others? Is
there any financial incentive for differential reporting between
the databases and could that in any way contribute toward the
discrepancy?
Dr Kozower. Excellent question. The NIS actually uses the
same discharge abstract data that is used to generate charges. So,
if there is intentional gamesmanship, it is truly fraud. However,
we all know that issues exist with the accuracy of administrative
data. The more we study our own administrative data, from the
University Healthsystem Consortium, the more issues we find.
For the STS database, the current audits have looked quite good.
Fortunately, no current advantage exists for ‘‘gaming’’ the systemgery c November 2012
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sure increases and the insurance companies ‘‘tighten the screws,’’
there will be some increased pressure to perform.
Dr Sugarbaker. Particularly because the STS database is now
being made available to certain insurers to assess quality for par-
ticular institutions regionally.
Dr Thomas K. Waddell (Toronto, Ontario, Canada). I had the
same concerns, but when I first read this abstract, Benji, and I know
you are such a methodological purist, I thought the purpose of this
study was to actually try to study the various qualities of different
types of databases, not to actually talk about that this proves that
this type of surgeon is better to do this operation in this type of
hospital.
So, returning to a good question; that is, can we look at the qual-
ity of data in these 3 databases, are there actually any overlapping
patient data that are in all 3 data sets? Is it possible to perform pa-
tient-level linkage? Is it possible to perform hospital-level linkage?
That would get to David’s question about what is the actual miss-
ing patient who often had, perhaps, died. Also, even to go a little bit
more broadly, could you actually construct some sort of quality as-
sessment of the data entered by linking to the Centers for Medicare
and Medicaid Services data to study items such as the reoperationThe Journal of Thoracic and Carrate as a method to judge the quality of not just the STS database
but, in fact, all of these data sets?
Dr Kozower. That is a great question. When I started this pro-
ject, my initial objective was to compare these different databases
at a national level. However, we cannot link them at a patient level
to compare the accuracy of data and reported outcomes such as
mortality, morbidity, and readmission. Although certain hospital
level characteristics can be linked between different databases, pa-
tients are deidentified.
I am sorry, I did not fully catch your question on the Centers for
Medicare and Medicaid Services.
DrWaddell. I was wondering if you could study reoperation as
an outcome metric of quality esophagectomy, or whatever, and
then use the Centers for Medicare and Medicaid Services data to
validate that; how many patients actually were there bills or
charges for associated with that reoperation. That could be one
method to validate. If you find that everybody is billing for 3 times
more reoperations than they claim to be performing in the STS da-
tabase, that might tell you something.
Dr Kozower. It is an excellent question and we could pool data
from a few hospitals to consider this, but we cannot do it for the
national databases.diovascular Surgery c Volume 144, Number 5 1159
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